Table 1.
Demographic | MRSA-VAP | Non-MRSA-VAP | P-value |
---|---|---|---|
Age | 68 (59–74) | 62 (44–73) | 0.03 |
Antibiotic treatment | 92 (82.9%) | 234 (64.5%) | <0.001 |
Abdominal surgery | 39 (35.1%) | 70 (19.3%) | <0.001 |
Presurgical antibiotic prophylaxis | 43 (38.7%) | 87 (24%) | 0.003 |